IMMD

ImmuDyne, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/18/2017
Contact Info
  • 50 Spring Meadow Rd
  • Mount Kisco, NY 10549

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000948320
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark McLaughlin President, CEO
Anthony Bruzzese, M.D. Outside Director
Sven Rohmann Outside Director
Ryan Aldridge Outside Director
Joseph DiTrolio Outside Director
Company Directors
John Strawn Chairman
Stefan Galluppi
Justin Schreiber
Company Notes
  • Formerly=Anina Resources, Inc to 11-87
Service Providers
Accounting/Auditing Firm
PKF O'Connor Davies, LLP
29 Broadway
New York, NY, 10006
United States

Legal Counsel Investor Relations Firm
Not Available
IMMD Security Details
Share Structure
Market Value1 $21,171,524 a/o Sep 18, 2017
Authorized Shares 50,000,000 a/o Sep 30, 2016
Outstanding Shares 44,107,342 a/o Jul 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 13,990,119 a/o Aug 15, 2016
Par Value 0.01
Transfer Agent(s)
Computershare
Shareholders
Shareholders of Record 324 a/o May 24, 2017
Short Selling Data
Short Interest 161,743 (-0.71%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security